Howe & Rusling’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Howe & Rusling’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9	Closed	–	–	1164
2016 Q2	$0	Hold	9	–	–	﹤0.01%	1080
2016 Q1	$0	Hold	9	–	–	﹤0.01%	1082
2015 Q4	$0	Hold	9	–	–	﹤0.01%	1106
2015 Q3	$0	Hold	9	–	–	﹤0.01%	1098
2015 Q2	$1K	Buy	+9	New	+$595	﹤0.01%	1008

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Howe & Rusling's ONCE Position: Q3 2016 in Review

Howe & Rusling sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2016, closing a stake of 9 shares.

Howe & Rusling first reported a position in ONCE in Q2 2015 and held it in 5 quarters. The position peaked at $1K in Q2 2015. 121 funds tracked by Wall St. Rank hold ONCE as of Q3 2016.

Howe & Rusling reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Howe & Rusling sold 9 Spark Therapeutics, Inc. Common Stock shares in Q3 2016.
Howe & Rusling first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 5 quarters.
Howe & Rusling's Spark Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2015.
121 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Howe & Rusling's 13F filing for Q3 2016, filed 17 Oct 2016.